Literature DB >> 22860903

MicroRNAs: possible role in pathogenesis of Parkinson's disease.

E V Filatova1, A Kh Alieva, M I Shadrina, P A Slominsky.   

Abstract

Parkinson's disease is one of the most common human neurodegenerative disorders caused by the loss of dopaminergic neurons from the substantia nigra pars compacta of human brain. However, causes and mechanisms of the progression of the disease are not yet fully clarified. To date, investigation of the role of miRNAs in norm and pathology is one of the most intriguing and actively developing areas in molecular biology. MiRNAs regulate expression of a variety of genes and can be implicated in pathogenesis of various diseases. Possible role of miRNAs in pathogenesis of Parkinson's disease is discussed in this review.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22860903     DOI： 10.1134/S0006297912080020

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN： 0006-2979            Impact factor:   2.487


  14 in total

1.  Differential response of miRNA-21 and its targets after traumatic brain injury in aging mice.

Authors:  Rajat Sandhir; Eugene Gregory; Nancy E J Berman
Journal:  Neurochem Int       Date:  2014-09-30       Impact factor: 3.921

2.  Single-nucleotide polymorphisms and haplotypes of non-coding area in the CP gene are correlated with Parkinson's disease.

Authors:  Na Zhao; Jianqiu Xiao; Zhiyong Zheng; Guoqiang Fei; Feng Zhang; Lirong Jin; Chunjiu Zhong
Journal:  Neurosci Bull       Date:  2015-03-10       Impact factor: 5.203

Review 3.  Extracellular vesicles in neurodegenerative disease - pathogenesis to biomarkers.

Authors:  Alexander G Thompson; Elizabeth Gray; Sabrina M Heman-Ackah; Imre Mäger; Kevin Talbot; Samir El Andaloussi; Matthew J Wood; Martin R Turner
Journal:  Nat Rev Neurol       Date:  2016-05-13       Impact factor: 42.937

Review 4.  Tiny But Mighty: Promising Roles of MicroRNAs in the Diagnosis and Treatment of Parkinson's Disease.

Authors:  Ying Wang; Zhaofei Yang; Weidong Le
Journal:  Neurosci Bull       Date:  2017-07-31       Impact factor: 5.203

Review 5.  Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies.

Authors:  Kira S Sheinerman; Samuil R Umansky
Journal:  Front Cell Neurosci       Date:  2013-09-10       Impact factor: 5.505

6.  Microarray analysis of transcriptome of medulla identifies potential biomarkers for Parkinson's disease.

Authors:  Xiao-Yang Liao; Wei-Wen Wang; Zheng-Hui Yang; Jun Wang; Hang Lin; Qing-Song Wang; Yu-Xian Wu; Yu Liu
Journal:  Int J Genomics       Date:  2013-11-20       Impact factor: 2.326

7.  Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology.

Authors:  Kasandra Burgos; Ivana Malenica; Raghu Metpally; Amanda Courtright; Benjamin Rakela; Thomas Beach; Holly Shill; Charles Adler; Marwan Sabbagh; Stephen Villa; Waibhav Tembe; David Craig; Kendall Van Keuren-Jensen
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

8.  LncRNA SNHG1 promotes neuronal injury in Parkinson's disease cell model by miR-181a-5p/CXCL12 axis.

Authors:  Hui Wang; Xiaopeng Wang; Yiying Zhang; Jianchuan Zhao
Journal:  J Mol Histol       Date:  2021-01-03       Impact factor: 2.611

9.  Expression levels of specific microRNAs are increased after exercise and are associated with cognitive improvement in Parkinson's disease.

Authors:  Franciele Cascaes Da Silva; Michele Patrícia Rode; Giovanna Grunewald Vietta; Rodrigo Da Rosa Iop; Tânia Beatriz Creczynski-Pasa; Alessandra Swarowsky Martin; Rudney Da Silva
Journal:  Mol Med Rep       Date:  2021-06-29       Impact factor: 2.952

10.  Molecule of the month: miRNA and Parkinson's disease protein PARK2.

Authors:  Paul Shapshak
Journal:  Bioinformation       Date:  2013-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.